PRESCRIPTION PATTERN OF DRUGS USED IN THE TREATMENT OF PEPTIC ULCER DISEASE IN THE DEPARTMENT OF GASTROENTEROLOGY IN A TERTIARY CARE HOSPITAL

被引:0
作者
Jayaram, Veeksha
Aiyappa, Cuckoo
Jallihal, Umesh
Shivamurthy, M. C.
机构
[1] MS Ramaiah Med Coll, Dept Pharmacol & Gastroenterol, Bangalore 560054, Karnataka, India
[2] Teaching Hosp, Bangalore 560054, Karnataka, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2014年 / 5卷 / 06期
关键词
Peptic ulcer disease; Retrospective study; Helicobacter pylori kit; Proton pump inhibitors;
D O I
10.13040/IJPSR.0975-8232.5(6).2418-22
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For more than a century Peptic Ulcer Disease (PUD) has been considered to be a major cause of morbidity and mortality. Most first line treatment for PUD involves use of acid suppressing drugs and target against the eradication of Helicobacter pylori (H. pylori) infection. However, the treatment strategy employed in India is not well studied. Hence, this study aims to provide insight into the prescription pattern of drugs used in PUD in India. The data was extracted from the medical records of all patients diagnosed with PUD from June 2011 to May 2012. A retrospective analysis was done to study the prescribing pattern of the drugs. The data was noted down on a pre-designed proforma and analysed. Records of 200 patients were assessed. About 91% of patients were prescribed anti H. pylori kit and the most commonly prescribed kit being Esomeprazole H. P kit (59.7%) followed by Pantoprazole H P kit. Following this, all patients were started on Proton pump inhibitors (PPI) for duration of about 6.89 +/- 2.25 weeks. On the basis of present study it was found that eradication of H. pylori is considered to be the most important treatment strategy in the management of PUD in India. Esomeprazole based HP kit was preferred, since several studies have shown them to be more efficacious. This was followed by a course of PPI to prevent recurrence.
引用
收藏
页码:2418 / 2422
页数:5
相关论文
共 25 条
  • [1] Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs:: A case-control study
    Aalykke, C
    Lauritsen, JM
    Hallas, J
    Reinholdt, S
    Krogfelt, K
    Lauritsen, K
    [J]. GASTROENTEROLOGY, 1999, 116 (06) : 1305 - 1309
  • [2] Abraham P, 1997, Indian J Gastroenterol, V16 Suppl 1, pS29
  • [3] Dewan R, 2000, Indian J Gastroenterol, V19 Suppl 1, pS11
  • [4] FELDMAN M, 1994, JAMA-J AM MED ASSOC, V272, P70
  • [5] Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
    Furuta, Takahisa
    Graham, David Y.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2010, 39 (03) : 465 - +
  • [6] Esomeprazole-based therapy in Helicobacter pylori eradication:: a meta-analysis
    Gisbert, JP
    Pajares, JM
    [J]. DIGESTIVE AND LIVER DISEASE, 2004, 36 (04) : 253 - 259
  • [7] Gisbert JP, 1996, REV ESP ENFERM DIG, V88, P259
  • [8] Go MF, 2002, ALIMENT PHARM THER, P1603
  • [9] Helicobacter pylori treatment in the era of increasing antibiotic resistance
    Graham, David Y.
    Fischbach, Lori
    [J]. GUT, 2010, 59 (08) : 1143 - 1153
  • [10] Role of Helicobacter pylori infection and non-steroidal antiinflammatory drugs in peptic-ulcer disease:: a meta-analysis
    Huang, JQ
    Sridhar, S
    Hunt, RH
    [J]. LANCET, 2002, 359 (9300) : 14 - 22